Skip to main content

Table 1 Genes over-expressed in JRA neutrophils

From: Evidence for chronic, peripheral activation of neutrophils in polyarticular juvenile rheumatoid arthritis

GenBank accession no.

Symbol

Description

Avg. control

Avg. patients

Ratio P/C

NM_001124

ADM

Adrenomedullin

0.3

3.2

10.3

NM_001706

BCL6

B-cell CLL/lymphoma 6 (zinc finger protein 51)

54.0

179.9

3.3

NM_001729

BTC

Betacellulin

0.2

2.8

12.1

NM_001295

CCR1

Chemokine (C-C motif) receptor 1

1.5

5.6

3.7

NM_001785

CDA

Cytidine deaminase

10.9

30.6

2.8

NM_004360

CDH1

Cadherin 1, type 1, E-cadherin (epithelial)

0.3

2.2

6.4

NM_005194

CEBPB

CCAAT/enhancer binding protein (C/EBP), beta

1.1

3.7

3.2

NM_000651

CR1

Complement component (3b/4b) receptor 1, including Knops blood group system

6.6

21.3

3.2

AF172398

F11R

F11 receptor, JAM1

0.5

3.5

7.2

NM_002005

FES

Feline sarcoma oncogene

35.6

108.3

3.0

NM_001462

FPRL1

Formyl peptide receptor-like 1

21.0

72.0

3.4

NM_000637

GSR

Glutathione reductase

3.7

18.5

5.0

NM_015401

HDAC7A

Histone deacetylase 7A

3.3

9.7

2.9

NM_002127

HLA-G

HLA-G histocompatibility antigen, class I, G

336.2

956.2

2.8

NM_005345

HSPA1A

Heat shock 70-kDa protein 1A

20.6

53.7

2.6

NM_014339

IL17R

Interleukin 17 receptor

10.2

28.5

2.8

NM_000634

IL8RA

Interleukin 8 receptor, alpha

13.6

53.9

4.0

BC017197

MCL1

Myeloid cell leukemia sequence 1 (BCL2-related)

5.3

21.5

4.1

NM_007289

MME

Membrane metallo-endopeptidase (neutral endopeptidase, enkephalinase, CALLA, CD10)

9.5

29.5

3.1

NM_013416

NCF4

Neutrophil cytosolic factor 4 (40 kDa)

20.0

58.6

2.9

AF171938

NUMB

Numb homolog (Drosophila)

3.2

11.6

3.7

NM_023914

P2RY13

purinergic receptor P2Y, G-protein coupled, 13, GPR86

8.7

32.0

3.7

NM_014143

PDCD1LG1

programmed cell death 1 ligand, B7-H1

0.3

5.1

15.3

NM_000442

PECAM1

Platelet/endothelial cell adhesion molecule (CD31 antigen)

6.2

12.5

2.0

NM_001198

PRDM1

PR domain containing 1, with ZNF domain

0.8

6.8

8.9

NM_000962

PTGS1

Prostaglandin-endoperoxide synthase 1 (prostaglandin G/H synthase and cyclooxygenase)

0.3

8.6

29.5

NM_002838

PTPRC

Protein tyrosine phosphatase, receptor type, C

55.9

159.7

2.9

NM_002881

RALB

V-ral simian leukemia viral oncogene homolog B (ras related-GTP binding protein)

5.2

15.8

3.0

NM_004761

RGL2

ral guanine nucleotide dissociation stimulator-like 2, RAB2

3.0

8.9

3.0

NM_005621

S100A12

S100 calcium binding protein A12 (calgranulin C)

62.9

164.0

2.6

NM_002964

S100A8

S100 calcium binding protein A8 (calgranulin A)

791.4

2,017.6

2.5

NM_002965

S100A9

S100 calcium binding protein A9 (calgranulin B)

1,152.7

2,697.1

2.3

D83782

SCAP

SREBP CLEAVAGE-ACTIVATING PROTEIN

0.3

2.6

7.5

NM_022464

SIL1

Endoplasmic reticulum chaperone SIL1, homolog of yeast

0.3

5.0

14.9

NM_004171

SLC1A2

Solute carrier family 1 (glial high affinity glutamate transporter), member 2

7.5

32.9

4.4

NM_001045

SLC6A4

Solute carrier family 6 (neurotransmitter transporter, serotonin), member 4

22.8

44.5

2.0

NM_003105

SORL1

Sortilin-related receptor, L(DLR class) A repeats-containing

31.9

89.7

2.8

NM_003153

STAT6

Signal transducer and activator of transcription 6, interleukin-4 induced

1.6

7.9

5.0

NM_003263

TLR1

Toll-like receptor 1

10.4

28.6

2.8

NM_003841

TNFRSF10C

Tumour necrosis factor receptor superfamily, member 10c, decoy without an intracellular domain

8.9

39.6

4.5

NM_006573

TNFSF13B

Tumour necrosis factor (ligand) superfamily, member 13b

9.2

22.4

2.4

NM_003329

TXN

Thioredoxin

9.0

24.8

2.8

  1. Avg. control, average (normalised) intensity in controls; Avg. patients = average (normalised) intensity in patients; Ratio P/C, fold difference between patients and controls.